Pacific Sun Financial Corp Has $634,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Pacific Sun Financial Corp lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 6.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,792 shares of the financial services provider’s stock after selling 355 shares during the period. Pacific Sun Financial Corp’s holdings in iShares Biotechnology ETF were worth $634,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Chicago Partners Investment Group LLC boosted its stake in shares of iShares Biotechnology ETF by 2.5% during the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock valued at $510,000 after purchasing an additional 94 shares in the last quarter. WealthCare Investment Partners LLC raised its holdings in iShares Biotechnology ETF by 0.9% in the 4th quarter. WealthCare Investment Partners LLC now owns 10,348 shares of the financial services provider’s stock valued at $1,375,000 after buying an additional 96 shares during the last quarter. Capital Investment Advisors LLC boosted its position in iShares Biotechnology ETF by 1.0% during the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after buying an additional 99 shares during the period. Magnus Financial Group LLC grew its holdings in iShares Biotechnology ETF by 0.8% during the 4th quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock worth $1,714,000 after acquiring an additional 104 shares during the last quarter. Finally, Burke & Herbert Bank & Trust Co. increased its position in iShares Biotechnology ETF by 1.2% in the 4th quarter. Burke & Herbert Bank & Trust Co. now owns 8,809 shares of the financial services provider’s stock valued at $1,165,000 after acquiring an additional 105 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.2 %

Shares of NASDAQ:IBB opened at $138.74 on Thursday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The firm’s fifty day moving average is $135.53 and its 200-day moving average is $140.79.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.